Our use of novel MS proteomics to identify NRP2 as a cargo of the Rab17–Vamp8 pathway indicates that loss of control over trafficking of this receptor is a key event in the DCIS to IDC transition. The gene discussed is NRP2; the disease is ductal breast carcinoma in situ.